NMD Pharma is clinical stage biotech company that focus on developing novel therapeutics for patients with neuromuscular disorders. The company was originally spun out from Biomedicine at Aarhus University. NMD Pharma is today an independent company in new facilities at Incuba Skejby and the company has around 30 employees. In 2018 NMD Pharma raised 38 MEUR from an international investor syndicate.
Established in 2015.
